HomeRNAC • NASDAQ
add
Cartesian Therapeutics Inc
Previous close
$16.62
Day range
$16.50 - $19.05
Year range
$11.67 - $42.60
Market cap
479.58M USD
Avg Volume
104.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 387.00K | -94.09% |
Operating expense | 6.56M | -0.79% |
Net income | -24.18M | -168.64% |
Net profit margin | -6.25K | -4,447.59% |
Earnings per share | -0.42 | — |
EBITDA | -17.29M | -34.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 219.20M | 3,088.33% |
Total assets | 455.32M | 4,789.56% |
Total liabilities | 454.56M | 14,572.82% |
Total equity | 752.00K | — |
Shares outstanding | 25.41M | — |
Price to book | 554.00 | — |
Return on assets | -10.94% | — |
Return on capital | 123.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.18M | -168.64% |
Cash from operations | 13.69M | 248.57% |
Cash from investing | -6.20M | — |
Cash from financing | 124.49M | 602.21% |
Net change in cash | 131.97M | 487.88% |
Free cash flow | 7.46M | — |
About
Founded
2007
Headquarters
Website
Employees
38
